Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.

Meliha C Kapetanovic, Lars Erik Kristensen, Tore Saxne, Teodora Aktas, Andreas Mörner, Pierre Geborek

Research output: Contribution to journalArticlepeer-review

46 Citations (SciVal)
147 Downloads (Pure)

Abstract

An adjuvanted pandemic H1N1 influenza (pH1N1) vaccine (Pandemrix®) was reported as highly immunogenic resulting in seroconversion in 77 to 94% of adults after administration of a single dose. The aim of the study was to investigate the impact of different anti-rheumatic treatments on antibody response to pH1N1 vaccination in patients with rheumatoid arthritis (RA) and spondylarthropathy (SpA).
Original languageEnglish
Article numberR2
JournalArthritis Research and Therapy
Volume16
Issue number1
DOIs
Publication statusPublished - 2014

Subject classification (UKÄ)

  • Rheumatology and Autoimmunity

Fingerprint

Dive into the research topics of 'Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.'. Together they form a unique fingerprint.

Cite this